| | | |
Early Onset
|
Late Onset
| |
Alden, 2006
|
USA
|
Cohort study, Level 3
|
Standard Purification Protocols
| | | |
Borysiak, 2020
|
Poland
|
Cohort study, Level 3
|
AxyPrep Blood Genomic DNA Miniprep Kit
| | | |
Buchan, July 2014
|
USA
|
Case–control cohort study, Level 3
|
Isolation Kit for Mammalian Blood or Oragene1 Purifier
| |
x
|
Trisomy X, 1.8% (2/114)
|
Buchan, May 2014
|
USA, China
|
Case–control cohort study, Level 3
|
Genome Analyzer IIx or HiSeq 2000 sequencer SureSelect Human All Exon 38 Mb and 50 Mb kits or TruSeq Exome Enrichment kit
| |
x
|
Marfan Syndrome
|
Kotwicki, 2014
|
Poland
|
Case–control study, Level 3
|
PCR restriction fragment length polymorphism (PCR–RFLP)
| | | |
Kou, 2019
|
Japan
|
Cohort study, Level 3
| |
x
| | |
Liu, 2017
|
China
|
Case–control association study, Level 3
|
Sequenom MassARRAY SNP genotyping platform
| | | |
Moon, 2013
|
South Korea
|
Case–control study, level 3
|
Single base primer extension assay
| |
x
| |
Nikolova, 2016
|
Bulgaria, Japan
|
Case–control study, Level 3
|
PCR
|
1–3 years of age (4) 3–9 years of age (23),
|
10–16 years of age (78)
| |
Ogura, 2013
|
Japan
|
Retrospective cohort study, Level 3
|
Invaer Assay
| | | |
Sadler, 2019
|
USA
|
Cohort study, Level 3
|
IDT xGen Exome Panel V1 capture on Illumina HiSeq 4000 paired-end reads
|
x
|
x
| |
Sharma, 2011
|
USA
|
Case–control cohort study, Level 3
|
Genotyped on Illumina Human CNV370-Quad arrays
| | | |
Takahashi, 2018
|
Japan
|
Case–control study, Level 3
|
PCR-based Invader assay
| |
x
| |
Takeda, 2017
|
Japan
|
Case–control study, Level 3
|
TaqMan real-time quantitative PCR, Microsatellite analysis, Sanger sequencing
| | |
Vertebral malformations
|
Wang, 2008
|
China
|
Cohort study, Level 3
|
PCR
|
x
|
x
| |
Wang, 2020
|
China
|
Cross-sectional study, Level 4
|
Whole-exome sequencing
| |
x
| |
Wu, 2006
|
China
|
Case–control study, level 3
|
PCR, Electrophoresis
| | | |
Xu, 2015
|
China
|
Retrospective case control study, Level 3
|
TaqMan SNP Genotyping Assay
| |
x
| |
Xu, 2020
|
China
|
Case–control association study, Level 3
|
Genome DNA Extraction with QIAGEN kit, Sanger Sequencing (10%), Exon Sequencing (192)
| | | |
Yilmaz, 2012
|
Turkey
|
Case–control study, level 3
|
RT-PCR
| | | |
Zhao, 2009
|
China
|
Case–control study, Level 3
|
QIAamp DNA Blood Mini kit
| |
x
| |
Zhao, 2020
|
China
|
Cohort study, Level 3
| |
x
| | |
Zhou, 2012
|
China
|
Case–control study, Level 3
|
PCR restriction fragment length polymorphism (PCR–RFLP)
| |
x
| |
Zhu, 2014
|
China
|
Case–control association study, Level 3
| | | | |